Literature DB >> 10666181

Sickle cell anemia day hospital: an approach for the management of uncomplicated painful crises.

L J Benjamin1, G I Swinson, R L Nagel.   

Abstract

Painful crisis episodes are poorly treated in sickle cell anemia, both in timeliness and appropriateness of care. Delayed treatment in Emergency Departments, unrelieved pain, frequent admissions, and prolonged hospitalizations are common. We established a Day Hospital (DH) to determine if an alternative care delivery system could improve pain relief and reduce unnecessary hospital admissions for patients with uncomplicated painful crises. Trained DH staff delivered prompt titration for pain relief based on each patient's analgesic history and qualitative and quantitative assessments. Response to therapy and comorbidities commanded disposition. During the first 5 years of DH operation there were 2554 visits; 60% of the patients had severe pain. During an average visit of 4.5 hours, 84% of the patients were titrated to relief; 90% had pain relief within 2 to 4 hours. Overall, 81% of the patients were discharged home (70% initially and 90% to 94% in the last 3 years). During the first 5 years of the DH, there were 2612 emergency department (ED) visits that averaged 13 hours each. The combined ED and DH admissions during this time represented a 40% decrease in the baseline ED admission rate of 92%, (1 year pre-DH). Patients with uncomplicated painful crisis were admitted 5 times less often from the DH (8.3%) than from the ED (42.7%). The length of stay (LOS) for inpatients followed by the DH staff decreased by 1.5 days, while the LOS for patients followed by non-DH staff remained unchanged. Reduction of admissions and LOS represented a savings of approximately $1.7 million. We conclude that a dedicated facility provides the kingpin for effective and rapid painful crisis management, reduces hospitalizations, and facilitates integration of the approach into other areas of care. (Blood. 2000;95:1130-1136)

Entities:  

Mesh:

Year:  2000        PMID: 10666181

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  46 in total

Review 1.  Managing sickle cell disease.

Authors:  Susan Claster; Elliott P Vichinsky
Journal:  BMJ       Date:  2003-11-15

2.  American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain.

Authors:  Amanda M Brandow; C Patrick Carroll; Susan Creary; Ronisha Edwards-Elliott; Jeffrey Glassberg; Robert W Hurley; Abdullah Kutlar; Mohamed Seisa; Jennifer Stinson; John J Strouse; Fouza Yusuf; William Zempsky; Eddy Lang
Journal:  Blood Adv       Date:  2020-06-23

3.  Emergency department visits made by patients with sickle cell disease: a descriptive study, 1999-2007.

Authors:  Hussain R Yusuf; Hani K Atrash; Scott D Grosse; Christopher S Parker; Althea M Grant
Journal:  Am J Prev Med       Date:  2010-04       Impact factor: 5.043

4.  Impact of a dedicated infusion clinic for acute management of adults with sickle cell pain crisis.

Authors:  Sophie Lanzkron; C Patrick Carroll; Peter Hill; Mandy David; Nicklaine Paul; Carlton Haywood
Journal:  Am J Hematol       Date:  2015-02-25       Impact factor: 10.047

5.  Outpatient pain predicts subsequent one-year acute health care utilization among adults with sickle cell disease.

Authors:  Miriam O Ezenwa; Robert E Molokie; Zaijie Jim Wang; Yingwei Yao; Marie L Suarez; Veronica Angulo; Diana J Wilkie
Journal:  J Pain Symptom Manage       Date:  2014-03-15       Impact factor: 3.612

6.  USING LIVED EXPERIENCES OF ADULTS TO UNDERSTAND CHRONIC PAIN: SICKLE CELL DISEASE, AN EXEMPLAR.

Authors:  Maxine A Adegbola
Journal:  Imanagers J Nurs       Date:  2011

7.  The impact of race and disease on sickle cell patient wait times in the emergency department.

Authors:  Carlton Haywood; Paula Tanabe; Rakhi Naik; Mary Catherine Beach; Sophie Lanzkron
Journal:  Am J Emerg Med       Date:  2013-02-04       Impact factor: 2.469

8.  Outpatient management of sickle cell pain with chronic opioid pharmacotherapy.

Authors:  Lauren Shaiova; David Wallenstein
Journal:  J Natl Med Assoc       Date:  2004-07       Impact factor: 1.798

9.  An unequal burden: poor patient-provider communication and sickle cell disease.

Authors:  Carlton Haywood; Shawn Bediako; Sophie Lanzkron; Marie Diener-West; John Strouse; Jennifer Haythornthwaite; Gladys Onojobi; Mary Catherine Beach
Journal:  Patient Educ Couns       Date:  2014-05-23

10.  Derivation and preliminary validation of a risk score to predict 30-day ED revisits for sickle cell pain.

Authors:  Jeffrey Glassberg; Jena Simon; Nilesh Patel; Jordan M Jeong; Justin J McNamee; Gary Yu
Journal:  Am J Emerg Med       Date:  2015-07-17       Impact factor: 2.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.